Overview

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cisplatin and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cisplatin together with temozolomide works in treating young patients with malignant glioma.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Cancer and Leukaemia Group
Treatments:
Cisplatin
Dacarbazine
Temozolomide